News
14 Jan, 2026

LAUGFS Life Sciences, in partnership with the Medical Research Institute (MRI) Colombo, has launched Sri Lanka’s first publicly driven allergy awareness wristbands, marking a significant step forward in patient safety and emergency preparedness.
The wristbands provide critical information on drug sensitivities, enabling healthcare professionals to respond quickly and effectively during medical emergencies when time is crucial.
The official handover ceremony was attended by leading medical professionals, including Head of the MRI Department of Immunology and Consultant Immunologist Dr. Dhanushka Dassanayake, Senior Consultant Immunologist Dr. Rajiva de Silva, and Deputy Director Dr. Prabath Amarasinghe.
LAUGFS Life Sciences CEO Dr. Rajiv Perera said the initiative reflects the company’s commitment to patient-centric healthcare. He noted that providing critical, life-saving information during emergencies can have a meaningful impact on patient outcomes, adding that the programme is expected to expand to include additional drugs and allergens in the future.
LAUGFS Life Sciences specialises in the manufacture of Large Volume Parenteral IV solutions for local and regional healthcare markets. The company operates a state-of-the-art facility at the BOI Export Processing Zone in Koggala and adheres to Current Good Manufacturing Practice guidelines set by the World Health Organisation, the National Medicines Regulatory Authority, and other global regulators.
With a portfolio of more than 20 IV fluid products, including electrolytes, dextrose solutions, and critical care medications, the company produces non-PVC polypropylene bags using advanced Form Fill Seal and Eurocap technologies. Its fully automated production process ensures high efficiency, product integrity, and consistent quality.
Recommended For You
Colombo Gazette is a leading news and entertainment website, covering stories related to Sri Lanka. The content consists of text based news, photos and videos and is linked to social media websites including Facebook, Twitter and Instagram, to provide a wider coverage for its stories.
Copyright © 2026 Colombo Gazette. All rights reserved.